Developer docs
API playgroundTry for free, no card

Search company profiles

CANSEARCH Foundation

Full company profile

uuid0042vek

Namestring
CANSEARCH Foundation
Legal namestring
CANSEARCH Foundation
Websiteurl
cansearch.ch
Company typeenum
Private
Founded yearint
2011
Descriptiontext

CANSEARCH Foundation is a Swiss non-profit foundation established in 2011 by Prof. Marc Ansari to finance pediatric oncology and hematology research within the Pediatric Oncology and Hematology Unit (UOHP) of the Geneva University Hospitals (HUG). The foundation operates through a public-private partnership with HUG and the University of Geneva, where it established the CANSEARCH Research Laboratory as the first dedicated pediatric onco-hematology research platform in Geneva. Its core technical capabilities center on multi-omic pharmacogenomics, transcriptomics, and CRISPR/Cas9 functional genomics for personalized medicine in pediatric cancer treatment, anchored by the BaHOP biobank (over 12,000 samples from 2,767+ patients) and the BISKIDS national germline DNA biobank. The biobank infrastructure holds VITA and NORMA certifications from the Swiss Biobanking Platform and is listed in the BBMRI-ERIC directory.

The foundation's product portfolio spans translational research programs (BuPGPK individualized therapy, RELIVE liver tumor registry, SWISSLIVERRE, HGG International Registry, neuroblastoma project), patient support initiatives (CANpalliative, CANsurvive, CANhelp, CANhypnosis, CANdrepano), clinical infrastructure (CANchimio computerized chemotherapy management), and fellowship/conference programs (CANmove, CANconnect, Visiting Doctor, Fellowship). Revenue is generated through charitable donations, peer-to-peer fundraising via the CANdo program, biennial charity galas (raising CHF 750K-1M per event), and competitive grants from SNSF, Swiss Cancer League, HUG Private Foundation, and the European Commission. Since 2011, CANSEARCH has published over 376 scientific manuscripts and 411 conference abstracts, contributed to a 20% improvement in 10-year survival rates for pediatric stem cell transplant recipients, and supported a 94% survival rate at the HUG pediatric oncology unit.

The foundation serves multiple stakeholder groups: pediatric cancer and blood disease patients treated at HUG, families requiring financial and logistical support, an international network of 200+ hospitals across 38+ countries collaborating on research, and individual donors and corporate sponsors (including Julius Baer, Novartis, and Roche). Strategic positioning is reinforced by the 2024 Swiss HSM national designation making HUG the centralized Swiss center for pediatric allogeneic HSCT and AML treatment, alongside competitive SNSF grants of approximately CHF 1 million awarded in 2025 for the FRESCO ototoxicity project.

Short descriptiontext

CANSEARCH Foundation is a Swiss non-profit funding pediatric oncology and hematology research at Geneva University Hospitals through pharmacogenomics, biobanking (12,000+ samples), and international clinical trials, serving children with cancer across 200+ hospitals in 38+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGeneva, Switzerland
HQ citystring
Geneva
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pediatric oncology research, childhood cancer research, pharmacogenomics research, pediatric biobanking, charitable research foundation
Industry5 codes
PRIMARYHLAKAFAE
Pediatric Hematology & Oncology
SECONDARYHLAIAIAN
Rare Pediatric & Congenital Disorder Therapies
Healthcare & Life Sciences/Pharmaceuticals/Orphan & Rare Disease Pharmaceuticals
SECONDARYHLAGAGAD
Cell Banking & Viral Seed Services (MCB/WCB/VSB)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAFAMAF
Toxicology & Therapeutic Drug Monitoring Laboratories
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Pediatric Oncology Research Foundation
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Charitable Donations
TypeGrants Donations
Description

The foundation raises funds primarily through individual donations via its online donation platform (pay.cansearch.ch), bank transfers, and standing orders. Donations are tax-exempt as the foundation is a recognized charity. The foundation explicitly states it does not provide individual or private support and does not accept spontaneous solicitation.

cansearch.ch
2Charity Gala Events
TypeGrants Donations
Description

Annual charity evening events (galas) serve as major fundraising vehicles. Ticket sales range from CHF 400 per individual to CHF 10,000 per support table. Past galas have raised CHF 750,000 (2013), CHF 850,000 (2015), nearly CHF 1,000,000 (2017, 2019). The 7th gala is planned for September 17, 2026.

cansearch.ch
3Corporate and Institutional Grants
TypeProfessional Services
Description

The foundation receives co-funding and project accreditation from prestigious institutions including the Swiss National Science Foundation (SNSF), Swiss Cancer League, HUG Private Foundation, Kinder Krebs Schweiz, and Swiss Biobank Platform. Competitive SNSF grants were obtained in 2025 for FINESS, FRESCO (GECCOS ototoxicity sub-project, ~1 million CHF), and a HUG relève grant.

cansearch.ch
4Corporate Sponsorship
TypeGrants Donations
Description

Corporate sponsors support the annual charity galas and fundraising initiatives. Past sponsors include Julius Baer, Novartis, Roche, and others from the pharma, finance, and luxury sectors.

cansearch.ch
5CANdo Peer-to-Peer Fundraising
TypeGrants Donations
Description

Volunteer-organized fundraising activities (sporting challenges, community events) through the CANdo program and the GivenGain platform, enabling supporters to organize their own donation campaigns.

cansearch.ch
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others
Pricing details2 tiers
1Individual gala ticket
ModelOtherBilling cadenceOne time
Notes

CHF 400 per person for the 2026 charity evening at Geneva Arena

pay.cansearch.ch
2Support table for 10 persons
ModelOtherBilling cadenceOne time
Notes

CHF 7,000 per table (including CHF 3,000 donation component) for the 2026 charity evening; CHF 10,000 per table (including CHF 6,000 donation component)

pay.cansearch.ch
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 12 records shown
1CANpalliative
Description

Pediatric palliative care program offering specialized follow-up for young cancer patients at end of life, as well as their parents and siblings.

cansearch.ch
+11 more records
Core offering1 text field

CANSEARCH Foundation funds and operates a pediatric oncology and hematology research platform embedded within the Geneva University Hospitals (HUG) and the University of Geneva. It conducts translational research using pharmacogenomics, transcriptomics, and CRISPR-based functional genomics to personalize treatments for children with cancer and blood diseases, maintains the BaHOP biobank with over 12,000 samples, and runs patient-support programs (CANpalliative, CANsurvive, CANhelp, CANhypnosis, CANdrepano) and international clinical registries (RELIVE, SWISSLIVERRE, HGG).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 94% survival rate at the HUG Pediatric Oncology and Hematology Unit
+6 more records
Product overview1 text field

CANSEARCH Foundation operates as a charitable research foundation supporting pediatric oncology and hematology through a portfolio of interconnected programs. The core offering is the CANSEARCH Research Platform, which coordinates multi-omics research including pharmacogenomics, transcriptomics, and genomic analysis for personalized medicine. Supporting infrastructure includes BaHOP Biobank for biological sample storage and management. The foundation funds patient support initiatives (CANpalliative, CANsurvive, CANhelp, CANhypnosis, CANdrepano), clinical training programs (Fellowship, Visiting Doctor, CANmove), knowledge-sharing platforms (CANconnect conferences), and investigator-initiated research grants (CANcure). Research registries including RELIVE (liver tumors), SWISSLIVERRE, HGG International Registry, and Neuroblastoma Project collect data to advance understanding of pediatric cancers. The computerized CANchimio system manages chemotherapy administration. Together these offerings form a comprehensive ecosystem from patient care through translational research to international collaboration.

Product and service16 records
1CANpalliative
CategoryPatient Support Program
Description

Pediatric palliative care program providing specialized follow-up for young cancer patients at end of life, including parents and siblings through palliative care consultations at the UOHP of HUG.

2CANsurvive
CategoryPatient Support Program
Description

Cancer survivor fellowship program funding long-term weekly consultations for pediatric cancer survivors, focused on early detection of treatment side effects, prevention programs, and fertility preservation.

3CANhelp
CategoryEmergency Family Support Fund
Description

Emergency support fund for families of children with cancer to access treatments and medications not covered by insurance, including housing assistance, funeral financing, therapeutic support, and aid for Ukrainian children with cancer arriving in Switzerland.

4CANhypnosis
CategoryTherapeutic Program
Description

Hypnotherapy program in pediatric oncology launched in November 2025, designed to transform children's experience of invasive procedures, reduce fear and pain, and restore a sense of control during treatment.

5CANdrepano
CategoryResearch Program
Description

Sickle cell disease (drepanocytosis) program aimed at improving care for children with this hereditary genetic blood disorder affecting hemoglobin and requiring sustained medical follow-up.

6CANchimio
CategoryClinical IT System
Description

Computerized chemotherapy management IT system implementing secure and traceable prescription, distribution, and administration of chemotherapeutic treatments in the pediatric oncology and hematology unit, optimizing patient safety.

7BaHOP Biobank
CategoryResearch Infrastructure / Biobank
Description

Geneva pediatric biobank for onco-hematology research (Banque genevoise pédiatrique pour la recherche en onco-hématologie), storing over 12,000 samples from more than 2,767 patients, with VITA and NORMA accreditations and international listing in BBMRI-ERIC directory.

8Individualized Therapy (BuPGPK Study)
CategoryResearch Program
Description

Personalized conditioning regimen research for busulfan-based myeloablative treatments before pediatric stem cell transplantation, using pharmacogenomics, transcriptomics, and in vitro functional analyses to identify genetic markers for optimal drug dosing.

9RELIVE Registry
CategoryInternational Clinical Registry
Description

International multicenter registry database for pediatric patients with recurrent or refractory hepatoblastoma or hepatocellular carcinoma, developed at HUG and deployed across 15 countries with secure data entry access for 64 participating centers.

10HGG International Registry
CategoryInternational Clinical Registry
Description

International registry for high-grade gliomas in children and infants, systematically collecting epidemiological, clinical, and molecular data to improve knowledge and treatment of pediatric brain tumors.

11SWISSLIVERRE Registry
CategoryNational Clinical Registry
Description

Swiss national registry for pediatric patients with malignant liver tumors, standardizing therapeutic strategies through a national tumor board coordinated across 9 Swiss pediatric oncology institutions.

12CANmove (Mobility Fellowship)
CategoryResearch Fellowship
Description

Mobility fellowship for pediatric oncology researchers or clinicians in French-speaking Switzerland to complete training abroad and return to share expertise, stimulating scientific dynamism in the region.

13CANconnect (Conference Program)
CategoryConference Program
Description

International congress and symposium organization program facilitating collaboration between specialists to implement multinational studies and expand research networks in pediatric oncology and hematology.

14CANcURE Research Grant
CategoryResearch Grant
Description

Biennial CANSEARCH Research Grant awarded to researchers across Switzerland studying pediatric oncology and hematology, with double selection by the Swiss Cancer League and CANSEARCH scientific committees.

15Visiting Doctor Fellowship
CategoryInternational Research Fellowship
Description

International physician-researcher fellowship engaging renowned experts at the CANSEARCH research platform, oriented 80% research and 20% clinical at the UOHP of HUG.

16Neuroblastoma Project
CategoryResearch Program
Description

Neuroblastoma research program using CRISPR/Cas9 library screening technology to identify synergistic genetic targets, combined with established therapies including eprenetapopt (PRIMA-1MET), ALK inhibitors, and cisplatin, with investigation of synthetic lethality approaches.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The foundation's primary institutional partner. CANSEARCH funds research within the Pediatric Oncology and Hematology Unit (UOHP) of the Department of Child and Adolescent of the Geneva University Hospitals. This public-private partnership provides a center for personalized and highly specialized pediatric onco-hematology medicine.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

The CANSEARCH Research Laboratory is embedded within the University of Geneva, providing academic research infrastructure and enabling faculty appointments (Prof. Marc Ansari was appointed Professor at the Medical Faculty of Geneva in November 2015).

Strategic tierMajorTypeStrategic or Co-development Partner
Description

One of Europe's most renowned oncology centers in Villejuif, France. Close collaboration accelerates access to innovative therapies and improves clinical protocols. Dr. Brice Fresneau, physician-researcher, has been regularly involved in the CANSEARCH research platform since October 2025, contributing to the ototoxicity project.

Strategic tierCoreTypeTechnology or Integration
Description

BaHOP is accredited by SBP (VITA, NORMA) and listed in biobankSQAN and BBMRI-ERIC directories. SwissRDL at ISPM University of Bern manages the Trust Center for data linkage across BISKIDS participants, ensuring secure BioLink ID-based matching.

5Swiss Pediatric Oncology Group (SPOG)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

National network of 9 Swiss pediatric oncology institutions (Aarau, Bern, Basel, Bellinzona, Geneva, Lausanne, Lucerne, St. Gallen, Zurich) participating in data collection for SWISSLIVERRE and other studies.

cansearch.ch
6ISPM University of Bern
Strategic tierMajorTypeTechnology or Integration
Description

The Institute of Social and Preventive Medicine at University of Bern manages BISKIDS clinical data through SwissRDL and hosts the national tumor board coordination for SWISSLIVERRE. The platform connects biobank resources across Switzerland.

cansearch.ch
Strategic tierMajorTypeStrategic or Co-development Partner
Description

International society providing scientific collaboration, conference participation, and knowledge sharing. CANSEARCH participates annually in SIOP congresses and contributes to international study networks.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

European society for blood and marrow transplantation. CANSEARCH presents studies at EBMT congresses (e.g., EBMT 2023 in Paris) and participates in EBMT working groups on pediatric HSCT.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

International society focused on pediatric liver tumors. CANSEARCH received Horizon 2020 funding to open the SIOPEL research program in Switzerland. RELIVE and PHITT studies are conducted in partnership with SIOPEL.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

CANSEARCH is affiliated with the Centre facultaire d'Investigation Translationnelle en Biomarqueurs (CITB) and the Centre Translationnel de Recherche en Oncologie et Hématologie (CRTOH), which is itself affiliated with the Swiss Cancer Center Leman (SCCL).

11International Research Centers for RELIVE (15 countries)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

RELIVE registry active in 15 countries: Switzerland, Spain, France, Belgium, Netherlands, Poland, Germany, UK, Ireland, USA, Canada, Japan, Australia, New Zealand, and Hong Kong, with 64 hospitals participating and over 360 children enrolled.

cansearch.ch
12BuGenes International Centers (19 centers)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

BuGenes study, CANSEARCH's flagship project, opens 19 centers across Europe (including UK), the Middle East, and Australia/New Zealand. Three additional centers in India, China, and Europe have expressed interest.

cansearch.ch
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Historic French cancer research and care institution with pediatric oncology activities; broader scope than CANSEARCH but highly comparable in translational research and patient care integration.

2Children's Hospital of Philadelphia (CHOP) Research Institute
TypeBroad incumbent
Description

Largest US children's hospital research enterprise; operates its own pediatric biobank and oncology trials. Much larger scope but operates comparable biobank and registry infrastructure.

TypeDirect peer
Description

The world's largest cooperative pediatric cancer research network running multi-site clinical trials. CANSEARCH participates in COG-adjacent networks (SIOP, SIOPEN, PHITT) and runs analogous registries (RELIVE, BuGenes).

TypeDirect peer
Description

Major US pediatric cancer research hospital with extensive biobanking, translational research, and international collaborations. Closest global analog to CANSEARCH in mission and scope, though at materially larger scale.

TypeDirect peer
Description

UK pediatric oncology center where Prof. Roderick Skinner (CANSEARCH advisor) is honorary professor. A directly comparable UK pediatric onco-hematology research group.

TypeDirect peer
Description

Leading European comprehensive cancer center in Villejuif, France; named CANSEARCH partner with Dr. Fresneau collaborating on ototoxicity research. Closest continental peer in pediatric onco-hematology research and trial participation.

TypeDirect peer
Description

Leading Canadian pediatric research hospital; named collaborator (Dr. Waespe's training background, Valentine Pradet from CHU Sainte-Justine affiliated). Comparable in pediatric oncology/hematology research mission.

8Swiss Pediatric Oncology Group (SPOG)
TypeDirect peer
Description

National network of 9 Swiss pediatric oncology institutions coordinating studies such as SWISSLIVERRE. CANSEARCH is an embedded research sponsor and SPOG board member; near-perfect operational peer in the same Swiss footprint.

TypeDirect peer
Description

International society running pediatric liver tumor trials (PHITT, RELIVE). CANSEARCH has a Horizon 2020 grant to run SIOPEL's Swiss program, making it both a peer and an operational partner.

TypeOthers
Description

Global scientific society coordinating pediatric oncology research; not a direct operational peer but the field's primary scientific convocation where CANSEARCH publishes and recruits collaborators.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles21 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CANSEARCH Foundation

Pediatric Oncology Research Foundationcansearch.ch

CANSEARCH Foundation is a Swiss non-profit funding pediatric oncology and hematology research at Geneva University Hospitals through pharmacogenomics, biobanking (12,000+ samples), and international clinical trials, serving children with cancer across 200+ hospitals in 38+ countries.

What CANSEARCH Foundation does

CANSEARCH Foundation is a Swiss non-profit foundation established in 2011 by Prof. Marc Ansari to finance pediatric oncology and hematology research within the Pediatric Oncology and Hematology Unit (UOHP) of the Geneva University Hospitals (HUG). The foundation operates through a public-private partnership with HUG and the University of Geneva, where it established the CANSEARCH Research Laboratory as the first dedicated pediatric onco-hematology research platform in Geneva. Its core technical capabilities center on multi-omic pharmacogenomics, transcriptomics, and CRISPR/Cas9 functional genomics for personalized medicine in pediatric cancer treatment, anchored by the BaHOP biobank (over 12,000 samples from 2,767+ patients) and the BISKIDS national germline DNA biobank. The biobank infrastructure holds VITA and NORMA certifications from the Swiss Biobanking Platform and is listed in the BBMRI-ERIC directory.

The foundation's product portfolio spans translational research programs (BuPGPK individualized therapy, RELIVE liver tumor registry, SWISSLIVERRE, HGG International Registry, neuroblastoma project), patient support initiatives (CANpalliative, CANsurvive, CANhelp, CANhypnosis, CANdrepano), clinical infrastructure (CANchimio computerized chemotherapy management), and fellowship/conference programs (CANmove, CANconnect, Visiting Doctor, Fellowship). Revenue is generated through charitable donations, peer-to-peer fundraising via the CANdo program, biennial charity galas (raising CHF 750K-1M per event), and competitive grants from SNSF, Swiss Cancer League, HUG Private Foundation, and the European Commission. Since 2011, CANSEARCH has published over 376 scientific manuscripts and 411 conference abstracts, contributed to a 20% improvement in 10-year survival rates for pediatric stem cell transplant recipients, and supported a 94% survival rate at the HUG pediatric oncology unit.

The foundation serves multiple stakeholder groups: pediatric cancer and blood disease patients treated at HUG, families requiring financial and logistical support, an international network of 200+ hospitals across 38+ countries collaborating on research, and individual donors and corporate sponsors (including Julius Baer, Novartis, and Roche). Strategic positioning is reinforced by the 2024 Swiss HSM national designation making HUG the centralized Swiss center for pediatric allogeneic HSCT and AML treatment, alongside competitive SNSF grants of approximately CHF 1 million awarded in 2025 for the FRESCO ototoxicity project.

CANSEARCH Foundation firmographics

Firmographics
Name
CANSEARCH Foundation
Legal name
CANSEARCH Foundation
Website
https://cansearch.ch
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
CANSEARCH Foundation is a Swiss non-profit funding pediatric oncology and hematology research at Geneva University Hospitals through pharmacogenomics, biobanking (12,000+ samples), and international clinical trials, serving children with cancer across 200+ hospitals in 38+ countries.
Ownership category
akta.pro rank

CANSEARCH Foundation industry classification

Industry
Product category
Pediatric Oncology Research Foundation
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (6215)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAKAFAE
Pediatric Hematology & Oncology
SECONDARYHLAIAIAN
Rare Pediatric & Congenital Disorder Therapies
Healthcare & Life Sciences/Pharmaceuticals/Orphan & Rare Disease Pharmaceuticals
SECONDARYHLAGAGAD
Cell Banking & Viral Seed Services (MCB/WCB/VSB)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAFAMAF
Toxicology & Therapeutic Drug Monitoring Laboratories

Keywords

  • Pediatric oncology research
  • Childhood cancer research
  • Pharmacogenomics research
  • Pediatric biobanking
  • Charitable research foundation

Where CANSEARCH Foundation is headquartered

Location

Headquarters

HQ city
Geneva
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

CANSEARCH Foundation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Charitable Donations: The foundation raises funds primarily through individual donations via its online donation platform (pay.cansearch.ch), bank transfers, and standing orders. Donations are tax-exempt as the foundation is a recognized charity. The foundation explicitly states it does not provide individual or private support and does not accept spontaneous solicitation.
  2. Charity Gala Events: Annual charity evening events (galas) serve as major fundraising vehicles. Ticket sales range from CHF 400 per individual to CHF 10,000 per support table. Past galas have raised CHF 750,000 (2013), CHF 850,000 (2015), nearly CHF 1,000,000 (2017, 2019). The 7th gala is planned for September 17, 2026.
  3. Corporate and Institutional Grants: The foundation receives co-funding and project accreditation from prestigious institutions including the Swiss National Science Foundation (SNSF), Swiss Cancer League, HUG Private Foundation, Kinder Krebs Schweiz, and Swiss Biobank Platform. Competitive SNSF grants were obtained in 2025 for FINESS, FRESCO (GECCOS ototoxicity sub-project, ~1 million CHF), and a HUG relève grant.
  4. Corporate Sponsorship: Corporate sponsors support the annual charity galas and fundraising initiatives. Past sponsors include Julius Baer, Novartis, Roche, and others from the pharma, finance, and luxury sectors.
  5. CANdo Peer-to-Peer Fundraising: Volunteer-organized fundraising activities (sporting challenges, community events) through the CANdo program and the GivenGain platform, enabling supporters to organize their own donation campaigns.

Pricing tiers

ModelBillingPrice
OtherOne timeIndividual gala ticket
OtherOne timeSupport table for 10 persons

Go-to-market motion2 records

Distribution channels5 records

Marketing channels9 records

CANSEARCH Foundation product offering

Product offering

Core offering

CANSEARCH Foundation funds and operates a pediatric oncology and hematology research platform embedded within the Geneva University Hospitals (HUG) and the University of Geneva. It conducts translational research using pharmacogenomics, transcriptomics, and CRISPR-based functional genomics to personalize treatments for children with cancer and blood diseases, maintains the BaHOP biobank with over 12,000 samples, and runs patient-support programs (CANpalliative, CANsurvive, CANhelp, CANhypnosis, CANdrepano) and international clinical registries (RELIVE, SWISSLIVERRE, HGG).

Product overview

CANSEARCH Foundation operates as a charitable research foundation supporting pediatric oncology and hematology through a portfolio of interconnected programs. The core offering is the CANSEARCH Research Platform, which coordinates multi-omics research including pharmacogenomics, transcriptomics, and genomic analysis for personalized medicine. Supporting infrastructure includes BaHOP Biobank for biological sample storage and management. The foundation funds patient support initiatives (CANpalliative, CANsurvive, CANhelp, CANhypnosis, CANdrepano), clinical training programs (Fellowship, Visiting Doctor, CANmove), knowledge-sharing platforms (CANconnect conferences), and investigator-initiated research grants (CANcure). Research registries including RELIVE (liver tumors), SWISSLIVERRE, HGG International Registry, and Neuroblastoma Project collect data to advance understanding of pediatric cancers. The computerized CANchimio system manages chemotherapy administration. Together these offerings form a comprehensive ecosystem from patient care through translational research to international collaboration.

Differentiator

Problem solved

Functional benefit

Brands

  • CANpalliative: Pediatric palliative care program offering specialized follow-up for young cancer patients at end of life, as well as their parents and siblings.
  • CANsurvive
  • CANhelp
  • CANhypnosis
  • CANdrepano
  • CANchimio
  • CANcURE
  • CANmove
  • CANconnect
  • Visiting Doctor
  • Fellowship
  • BaHOP

Products and services

  • CANpalliative Pediatric palliative care program providing specialized follow-up for young cancer patients at end of life, including parents and siblings through palliative care consultations at the UOHP of HUG.
  • CANsurvive Cancer survivor fellowship program funding long-term weekly consultations for pediatric cancer survivors, focused on early detection of treatment side effects, prevention programs, and fertility preservation.
  • CANhelp Emergency support fund for families of children with cancer to access treatments and medications not covered by insurance, including housing assistance, funeral financing, therapeutic support, and aid for Ukrainian children with cancer arriving in Switzerland.
  • CANhypnosis Hypnotherapy program in pediatric oncology launched in November 2025, designed to transform children's experience of invasive procedures, reduce fear and pain, and restore a sense of control during treatment.
  • CANdrepano Sickle cell disease (drepanocytosis) program aimed at improving care for children with this hereditary genetic blood disorder affecting hemoglobin and requiring sustained medical follow-up.
  • CANchimio Computerized chemotherapy management IT system implementing secure and traceable prescription, distribution, and administration of chemotherapeutic treatments in the pediatric oncology and hematology unit, optimizing patient safety.
  • BaHOP Biobank Geneva pediatric biobank for onco-hematology research (Banque genevoise pédiatrique pour la recherche en onco-hématologie), storing over 12,000 samples from more than 2,767 patients, with VITA and NORMA accreditations and international listing in BBMRI-ERIC directory.
  • Individualized Therapy (BuPGPK Study) Personalized conditioning regimen research for busulfan-based myeloablative treatments before pediatric stem cell transplantation, using pharmacogenomics, transcriptomics, and in vitro functional analyses to identify genetic markers for optimal drug dosing.
  • RELIVE Registry International multicenter registry database for pediatric patients with recurrent or refractory hepatoblastoma or hepatocellular carcinoma, developed at HUG and deployed across 15 countries with secure data entry access for 64 participating centers.
  • HGG International Registry International registry for high-grade gliomas in children and infants, systematically collecting epidemiological, clinical, and molecular data to improve knowledge and treatment of pediatric brain tumors.
  • SWISSLIVERRE Registry Swiss national registry for pediatric patients with malignant liver tumors, standardizing therapeutic strategies through a national tumor board coordinated across 9 Swiss pediatric oncology institutions.
  • CANmove (Mobility Fellowship) Mobility fellowship for pediatric oncology researchers or clinicians in French-speaking Switzerland to complete training abroad and return to share expertise, stimulating scientific dynamism in the region.
  • CANconnect (Conference Program) International congress and symposium organization program facilitating collaboration between specialists to implement multinational studies and expand research networks in pediatric oncology and hematology.
  • CANcURE Research Grant Biennial CANSEARCH Research Grant awarded to researchers across Switzerland studying pediatric oncology and hematology, with double selection by the Swiss Cancer League and CANSEARCH scientific committees.
  • Visiting Doctor Fellowship International physician-researcher fellowship engaging renowned experts at the CANSEARCH research platform, oriented 80% research and 20% clinical at the UOHP of HUG.
  • Neuroblastoma Project Neuroblastoma research program using CRISPR/Cas9 library screening technology to identify synergistic genetic targets, combined with established therapies including eprenetapopt (PRIMA-1MET), ALK inhibitors, and cisplatin, with investigation of synthetic lethality approaches.

Quantifiable outcome

  • 94% survival rate at the HUG Pediatric Oncology and Hematology Unit
  • +6 more outcomes

Companies that use CANSEARCH Foundation

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

CANSEARCH Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

CANSEARCH Foundation partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and major.

  • HUG (Geneva University Hospitals) - Pediatric Oncology and Hematology Unit (UOHP)coreStrategic or Co-development PartnerThe foundation's primary institutional partner. CANSEARCH funds research within the Pediatric Oncology and Hematology Unit (UOHP) of the Department of Child and Adolescent of the Geneva University Hospitals. This public-private partnership provides a center for personalized and highly specialized pediatric onco-hematology medicine.
  • University of GenevacoreStrategic or Co-development PartnerThe CANSEARCH Research Laboratory is embedded within the University of Geneva, providing academic research infrastructure and enabling faculty appointments (Prof. Marc Ansari was appointed Professor at the Medical Faculty of Geneva in November 2015).
  • Gustave Roussy Institute (France)majorStrategic or Co-development PartnerOne of Europe's most renowned oncology centers in Villejuif, France. Close collaboration accelerates access to innovative therapies and improves clinical protocols. Dr. Brice Fresneau, physician-researcher, has been regularly involved in the CANSEARCH research platform since October 2025, contributing to the ototoxicity project.
  • Swiss Biobanking Platform (SBP) / SwissRDLcoreTechnology or IntegrationBaHOP is accredited by SBP (VITA, NORMA) and listed in biobankSQAN and BBMRI-ERIC directories. SwissRDL at ISPM University of Bern manages the Trust Center for data linkage across BISKIDS participants, ensuring secure BioLink ID-based matching.
  • Swiss Pediatric Oncology Group (SPOG)coreStrategic or Co-development PartnerNational network of 9 Swiss pediatric oncology institutions (Aarau, Bern, Basel, Bellinzona, Geneva, Lausanne, Lucerne, St. Gallen, Zurich) participating in data collection for SWISSLIVERRE and other studies.
  • ISPM University of BernmajorTechnology or IntegrationThe Institute of Social and Preventive Medicine at University of Bern manages BISKIDS clinical data through SwissRDL and hosts the national tumor board coordination for SWISSLIVERRE. The platform connects biobank resources across Switzerland.
  • SIOP (International Society of Paediatric Oncology)majorStrategic or Co-development PartnerInternational society providing scientific collaboration, conference participation, and knowledge sharing. CANSEARCH participates annually in SIOP congresses and contributes to international study networks.
  • EBMT (European Society for Blood and Marrow Transplantation)majorStrategic or Co-development PartnerEuropean society for blood and marrow transplantation. CANSEARCH presents studies at EBMT congresses (e.g., EBMT 2023 in Paris) and participates in EBMT working groups on pediatric HSCT.
  • SIOPEL (International Society of Paediatric Oncology for Liver Tumours)majorStrategic or Co-development PartnerInternational society focused on pediatric liver tumors. CANSEARCH received Horizon 2020 funding to open the SIOPEL research program in Switzerland. RELIVE and PHITT studies are conducted in partnership with SIOPEL.
  • CITB and CRTOH / Swiss Cancer Center Leman (SCCL)majorStrategic or Co-development PartnerCANSEARCH is affiliated with the Centre facultaire d'Investigation Translationnelle en Biomarqueurs (CITB) and the Centre Translationnel de Recherche en Oncologie et Hématologie (CRTOH), which is itself affiliated with the Swiss Cancer Center Leman (SCCL).
  • International Research Centers for RELIVE (15 countries)coreStrategic or Co-development PartnerRELIVE registry active in 15 countries: Switzerland, Spain, France, Belgium, Netherlands, Poland, Germany, UK, Ireland, USA, Canada, Japan, Australia, New Zealand, and Hong Kong, with 64 hospitals participating and over 360 children enrolled.
  • BuGenes International Centers (19 centers)coreStrategic or Co-development PartnerBuGenes study, CANSEARCH's flagship project, opens 19 centers across Europe (including UK), the Middle East, and Australia/New Zealand. Three additional centers in India, China, and Europe have expressed interest.

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

CANSEARCH Foundation competitors and assessment

Company assessment

Broad incumbents

  • Institut Curie: Historic French cancer research and care institution with pediatric oncology activities; broader scope than CANSEARCH but highly comparable in translational research and patient care integration.
  • Children's Hospital of Philadelphia (CHOP) Research Institute: Largest US children's hospital research enterprise; operates its own pediatric biobank and oncology trials. Much larger scope but operates comparable biobank and registry infrastructure.

Direct peers

  • Children's Oncology Group (COG): The world's largest cooperative pediatric cancer research network running multi-site clinical trials. CANSEARCH participates in COG-adjacent networks (SIOP, SIOPEN, PHITT) and runs analogous registries (RELIVE, BuGenes).
  • St. Jude Children's Research Hospital: Major US pediatric cancer research hospital with extensive biobanking, translational research, and international collaborations. Closest global analog to CANSEARCH in mission and scope, though at materially larger scale.
  • Great North Children's Hospital / Newcastle University: UK pediatric oncology center where Prof. Roderick Skinner (CANSEARCH advisor) is honorary professor. A directly comparable UK pediatric onco-hematology research group.
  • Gustave Roussy Institute: Leading European comprehensive cancer center in Villejuif, France; named CANSEARCH partner with Dr. Fresneau collaborating on ototoxicity research. Closest continental peer in pediatric onco-hematology research and trial participation.
  • Hospital for Sick Children (SickKids), Toronto: Leading Canadian pediatric research hospital; named collaborator (Dr. Waespe's training background, Valentine Pradet from CHU Sainte-Justine affiliated). Comparable in pediatric oncology/hematology research mission.
  • Swiss Pediatric Oncology Group (SPOG): National network of 9 Swiss pediatric oncology institutions coordinating studies such as SWISSLIVERRE. CANSEARCH is an embedded research sponsor and SPOG board member; near-perfect operational peer in the same Swiss footprint.
  • SIOPEL (International Childhood Liver Tumours Strategy Group): International society running pediatric liver tumor trials (PHITT, RELIVE). CANSEARCH has a Horizon 2020 grant to run SIOPEL's Swiss program, making it both a peer and an operational partner.

Others

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

CANSEARCH Foundation social profiles

Digital presence

CANSEARCH Foundation compliance and trust

Trust signal

Compliance2 records

CANSEARCH Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CANSEARCH Foundation leadership team

Management profile

Number of profiles

Profiles21 records

CANSEARCH Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CANSEARCH Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CANSEARCH Foundation

What does CANSEARCH Foundation do?

CANSEARCH Foundation funds and operates a pediatric oncology and hematology research platform embedded within the Geneva University Hospitals (HUG) and the University of Geneva. It conducts translational research using pharmacogenomics, transcriptomics, and CRISPR-based functional genomics to personalize treatments for children with cancer and blood diseases, maintains the BaHOP biobank with over 12,000 samples, and runs patient-support programs (CANpalliative, CANsurvive, CANhelp, CANhypnosis, CANdrepano) and international clinical registries (RELIVE, SWISSLIVERRE, HGG).

Is CANSEARCH Foundation a public or private company?

CANSEARCH Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was CANSEARCH Foundation founded?

CANSEARCH Foundation was founded in 2011. It employs 11 to 50 people.

Where is CANSEARCH Foundation based?

CANSEARCH Foundation is headquartered in Geneva, Switzerland, in the Europe region.

How does CANSEARCH Foundation make money?

Five revenue lines are on record. Charitable Donations are the primary driver. The others are charity Gala Events, corporate and Institutional Grants, corporate Sponsorship and CANdo Peer-to-Peer Fundraising.

Who are CANSEARCH Foundation's main competitors?

Broad incumbents on record are Institut Curie and Children's Hospital of Philadelphia (CHOP) Research Institute. Direct peers are Children's Oncology Group (COG), St. Jude Children's Research Hospital, Great North Children's Hospital / Newcastle University, Gustave Roussy Institute, Hospital for Sick Children (SickKids), Toronto, Swiss Pediatric Oncology Group (SPOG) and SIOPEL (International Childhood Liver Tumours Strategy Group). SIOP (International Society of Paediatric Oncology) is listed as an others.

Does CANSEARCH Foundation have an API?

No public API is recorded for CANSEARCH Foundation.

What industry is CANSEARCH Foundation in?

CANSEARCH Foundation's product category is Pediatric Oncology Research Foundation. Its primary akta.pro industry code is HLAKAFAE, Pediatric Hematology & Oncology, with a secondary code of HLAIAIAN, Rare Pediatric & Congenital Disorder Therapies. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales